子宫内膜容受性检测在整倍体胚胎移植反复种植失败患者中的疗效:一项随机对照试验的研究方案
本研究为前瞻性、单盲、平行组随机对照试验,按1:1比例将反复种植失败且计划行整倍体胚胎冻融移植的患者随机分为两组。干预组接受基于RNA-Seq的子宫内膜容受性检测并据此指导个性化胚胎移植,对照组接受标准胚胎移植,主要结局为活产率。
要点
- 拟纳入反复种植失败且至少有一个整倍体囊胚可移植的患者。
- 干预组根据RNA-Seq子宫内膜容受性检测结果行个性化胚胎移植。
- 主要结局为活产率,两组按1:1随机分配。
核心结论
- 本研究结果将为子宫内膜容受性检测指导的个性化胚胎移植对反复种植失败患者妊娠结局的影响提供证据。
研究设计与样本
- 前瞻性、单盲、平行组随机对照试验,个性化胚胎移植与标准胚胎移植按1:1比例随机分组。
- 纳入反复种植失败、计划在胚胎植入前非整倍体遗传学检测后行冻融胚胎移植且至少有一个整倍体囊胚可移植的不孕女性。
关键数值与推荐
- 干预组接受子宫内膜容受性检测,并基于检测结果行个性化胚胎移植。
- 对照组接受标准胚胎移植。
- 主要结局为活产率。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Embryo implantation remains a critical barrier in assisted reproductive technologies. One of the main causes of unsuccessful embryo implantation is window of implantation (WOI) displacement, particularly in patients with recurrent implantation failure (RIF). Therefore, a reliable diagnostic tool for identifying the optimal WOI is essential. Previous data has suggested that a novel RNA-Seq-based endometrial receptivity testing (ERT) can diagnose WOI, guide personalized embryo transfer (pET), and improve pregnancy outcomes in patients with RIF compared to standard embryo transfer (sET). However, there is still a lack of evidence from randomized controlled trials (RCT) with sufficient power to determine whether pET based on ERT can increase the rate of live births as the primary outcome. METHODS: This trial is a prospective, single-blind, parallel-group RCT (1:1 ratio of pET versus sET). Infertile women with RIF who intend to undergo frozen-thawed embryo transfer (FET) after preimplantation genetic testing for aneuploidy (PGT-A) with the availability of at least one euploid blastocyst for transfer will be enrolled and assigned into two parallel groups randomly. Participants in the intervention group will undergo ERT and then pET based on the results of ERT, while those in the control group will undergo sET. The primary outcome is live birth rate. DISCUSSION: The findings of this study will provide evidence for the effect of pET guided by ERT on pregnancy outcomes in patients with RIF. TRIAL REGISTRATION: Chinese Clinical Trial Registry ChiCTR2100049041. Registered on 20 July 2021.
引用
- Lu Y, Mao X, He Y, et al. Efficacy of endometrial receptivity testing for recurrent implantation failure in patients with euploid embryo transfers: study protocol for a randomized controlled trial. Trials. 2024. PMID: 38807239. doi:10.1186/s13063-024-08125-6
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。